ask="N/A"
ask_size="N/A"
average_daily_volume="422650"
bid="16.10"
bid_size="100"
book_value="8.16"
change="+0.24"
change_from_200_day_moving_average="0.48"
change_from_50_day_moving_average="1.03"
change_from_52_week_high="-4.26"
change_From_52_week_low="8.71"
change_in_percent="+1.20%"
close="20.31"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.14"
ebitda="-16.56M"
eps_estimate_current_year="-1.32"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.11"
ex_dividend_date="N/A"
float_shares="21949000"
high="20.58"
high_52_weeks="24.57"
last_trade_date="2/7/2017"
last_trade_price="20.31"
last_trade_size="18795"
last_trade_time="4:00pm"
low="19.89"
low_52_weeks="11.60"
market_capitalization="766.34M"
moving_average_200_day="19.83"
moving_average_50_day="19.28"
name="Retrophin
Inc."
notes="N/A"
one_year_target_price="34.67"
open="20.10"
pe_ratio="N/A"
peg_ratio="-0.76"
percent_change_from_200_day_moving_average="+2.43%"
percent_change_from_50_day_moving_average="+5.34%"
percent_change_from_52_week_high="-17.34%"
percent_change_from_52_week_low="+75.09%"
previous_close="20.07"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.46"
price_per_sales="5.98"
revenue="126.71M"
shares_outstanding="37732000"
short_ratio="14.25"
stock_exchange="NGM"
symbol="RTRX"
volume="427888"
weeks_range_52="11.60 - 24.57"
